Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is 15.32% vs 4.06% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 1,750.00% vs 131.58% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is 102.02% vs 30.26% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is -1.37% vs -1.35% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
Compare Quarterly Results Of Xeris Biopharma Holdings, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2025 is 15.32% vs 4.06% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 42.76% vs 35.36% in Dec 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 1,750.00% vs 131.58% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 317.65% vs 61.94% in Dec 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2025 is 102.02% vs 30.26% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 316.67% vs 172.73% in Dec 2024
Quarterly - Interest
QoQ Growth in quarter ended Dec 2025 is -1.37% vs -1.35% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -6.49% vs 10.00% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024






